Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Corcept Therapeutics Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 226 | 2 | 239 | +15 |
| Shares | 84.0M | 103 | 87.0M | +3.04M (+3.6%) |
| Value | $2.02B | $2.00K | $2.23B | +$207.4M (+10.2%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Corcept Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Corcept Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 46,489 | $1.11M |
| Cambridge Trust Co | 30,200 | $718.0K |
| ExodusPoint Capital Management, LP | 19,210 | $457.0K |
| Capital Fund Management S.A. | 18,594 | $442.2K |
| Truist Financial Corp | 15,295 | $364.0K |
| Alps Advisors Inc | 14,486 | $344.0K |
| Ground Swell Capital, LLC | 13,545 | $322.0K |
| Sumitomo Mitsui Trust Holdings, Inc. | 12,007 | $286.0K |
| Wealth Architects, LLC | 10,005 | $238.0K |
| Quantamental Technologies LLC | 9,906 | $236.0K |
| Lion Street Advisors, LLC | 11,750 | $216.0K |
| State of Wyoming | 1,719 | $41.0K |
| Gladius Capital Management LP | 1,288 | $31.0K |
| Simplex Trading, LLC | 165 | $3.00K |
| Northwestern Mutual Wealth Management Co | 50 | $1.00K |
| Patriot Financial Group Insurance Agency, LLC | 24 | $1.00K |
| BDO Wealth Advisors, LLC | 35 | $1.00K |
| Steward Financial Group LLC | 45 | $1.00K |
| Private Ocean, LLC | 6 | $0 |
Not filed for Q3 2022 yet (2)
Institutions that held Corcept Therapeutics Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 60 | $1.00K |
| Private Capital Group, LLC | 43 | $1.00K |